WEIR SCIENCE LIMITED – Trademark Portfolio

Entity Type: 99

WEIR SCIENCE LIMITED holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include ATOPIS and MYREGYNA.

Unit 2, 5 Topere Way,

Westgate Auckland 0814

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

WEIR SCIENCE LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (3 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does WEIR SCIENCE LIMITED have?

WEIR SCIENCE LIMITED has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending, 1 abandoned.

What trademark classes does WEIR SCIENCE LIMITED file in?

WEIR SCIENCE LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are WEIR SCIENCE LIMITED's most well-known trademarks?

WEIR SCIENCE LIMITED's registered trademark portfolio includes well-known marks such as ATOPIS and MYREGYNA. These are among 2 currently registered trademarks in the portfolio.

What is WEIR SCIENCE LIMITED's trademark registration success rate?

WEIR SCIENCE LIMITED has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.